2019 IPO

10X Genomics Stock

Innovative Genomics Platform

Sign up today and learn more about 10X Genomics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

Founded

2012

Notable Investors

Fidelity Investments

Headquarters

Pleasanton CA, US

Total Funding

$238M

About 10X Genomics Stock

10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome.

Investors

Funding History

October 2012$3.0M
January 2015$55.0M
March 2016$55.0M
April 2018$50.0M
April 2018$75.0M

Management

Co-founder & CEO

Serge Saxonov

Chief Scientific Officer, President, Co-founder

Ben Hindson

Chief Commercial Officer

Brad Crutchfield

Press

Technology Networks - Jun, 23 2018

10x Genomics Extends their Application Portfolio

Business Wire (press release) - Apr, 5 2018

10x Genomics Becomes a Partner in the CanSeq150 Initiative

Business Wire (press release) - Feb, 21 2018

10x Genomics Joins EMBL's Corporate Partnership Program

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo